CRISPR Therapeutics AG (CRSP) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 2.45B | 1.98B | 1.93B | 1.73B | 1.87B | 1.94B | 1.94B | 2.01B | 2.12B | 1.91B | 1.76B | 1.86B |
| Cash & Short-Term Investments | 2.44B | 1.98B | 1.92B | 1.72B | 1.86B | 1.9B | 1.94B | 2B | 2.11B | 1.69B | 1.74B | 1.77B |
| Cash Only | 423.31M | 355.19M | 290.01M | 197.13M | 235.18M | 298.26M | 225.67M | 484.47M | 707.43M | 389.48M | 527.76M | 444.8M |
| Short-Term Investments | 2.02B | 1.63B | 1.63B | 1.53B | 1.62B | 1.61B | 1.71B | 1.52B | 1.4B | 1.3B | 1.21B | 1.32B |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 25M | 0 | 0 | 0 | 200M | 0 | 70M |
| Days Sales Outstanding | - | - | - | - | - | 65.71 | - | - | - | 92 | - | 91 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 6.58M | 0 | 13.38M | 8.91M | 12.33M | 8.31M | 8.25M | 8.79M | 11.5M | 6.5M | 0 | 0 |
| Total Non-Current Assets | 277.46M | 279.57M | 316.22M | 296.05M | 298.49M | 304.9M | 312.24M | 329.45M | 319.39M | 321.49M | 326.24M | 337.44M |
| Property, Plant & Equipment | 240.85M | 0 | 255.49M | 262.57M | 269.7M | 277.55M | 284.83M | 291.57M | 298.51M | 305.94M | 312.34M | 318.52M |
| Fixed Asset Turnover | 0.01x | - | 0.00x | 0.00x | 0.00x | 0.12x | 0.00x | 0.00x | 0.00x | 0.65x | - | 0.22x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2K | 16K | 30K | 43K |
| Long-Term Investments | 0 | 0 | 28.41M | 30.61M | 0 | 0 | 0 | 11.22M | 11.52M | 1.97M | 0 | 4.9M |
| Other Non-Current Assets | 36.61M | 279.57M | 32.31M | 2.87M | 28.79M | 27.35M | 27.41M | 26.66M | 20.88M | 13.57M | 13.88M | 13.97M |
| Total Assets | 2.73B | 2.27B | 2.25B | 2.03B | 2.17B | 2.24B | 2.26B | 2.34B | 2.44B | 2.23B | 2.09B | 2.2B |
| Asset Turnover | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.02x | 0.00x | 0.00x | 0.00x | 0.09x | - | 0.03x |
| Asset Growth % | 25.84% | 1.04% | -0.48% | -13.25% | -11.19% | 0.56% | 8.11% | 6.5% | 8.67% | -0.6% | -11.33% | -10.81% |
| Total Current Liabilities | 136.29M | 149.12M | 118.96M | 104.36M | 119.45M | 87.78M | 89.81M | 127.82M | 118.99M | 108.79M | 111.23M | 132.84M |
| Accounts Payable | 13.65M | 11.14M | 11.8M | 9.75M | 13.06M | 14.71M | 15.58M | 9.45M | 16.46M | 38.15M | 26.15M | 27.59M |
| Days Payables Outstanding | 22.2 | 17.77 | 15.32 | 20.87 | 21.73 | - | 72.17 | 20.7 | 47.97 | 147.89 | 105.54 | 74.15 |
| Short-Term Debt | 18.61M | 18.58M | 18.26M | 18.03M | 17.51M | 17.29M | 16.88M | 16.45M | 15.99M | 15.63M | 15M | 14.83M |
| Deferred Revenue (Current) | 15.34M | 15.77M | 1.29M | 2.13M | 3.02M | 3.85M | 4.48M | 4.76M | 4.07M | 4.11M | 3.5M | 0 |
| Other Current Liabilities | 88.05M | 89.55M | 74.03M | 65.12M | 78.53M | 33.05M | 36.93M | 82.33M | 73.78M | 33.13M | 50.51M | 77.27M |
| Current Ratio | 17.96x | 13.25x | 16.22x | 16.61x | 15.64x | 22.07x | 21.64x | 15.73x | 17.81x | 17.54x | 15.83x | 14.00x |
| Quick Ratio | 17.96x | 13.25x | 16.22x | 16.61x | 15.64x | 22.07x | 21.64x | 15.73x | 17.81x | 17.54x | 15.83x | 14.00x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 774.98M | 194.31M | 210.37M | 214.22M | 217.5M | 222.17M | 226.66M | 231.08M | 236.09M | 237.98M | 247.8M | 248.15M |
| Long-Term Debt | 585.47M | 188.17M | 192.77M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 183.56M | 188.17M | 192.77M | 197.43M | 201.85M | 206.41M | 210.66M | 214.85M | 218.94M | 223.01M | 226.59M | 230.34M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 5.95M | -182.03M | -187.49M | 4.48M | 3.32M | 3.44M | 3.68M | 3.65M | 3.62M | 958K | 5.39M | 5.48M |
| Total Liabilities | 911.26M | 343.43M | 329.33M | 318.59M | 336.94M | 309.95M | 316.47M | 358.9M | 355.08M | 346.77M | 359.04M | 380.99M |
| Total Debt | 787.64M | 394.91M | 403.79M | 215.45M | 219.36M | 223.69M | 227.54M | 231.3M | 234.93M | 238.63M | 241.59M | 245.18M |
| Net Debt | 364.33M | 39.73M | 113.78M | 18.32M | -15.83M | -74.56M | 1.88M | -253.17M | -472.5M | -150.84M | -286.18M | -199.62M |
| Debt / Equity | 0.43x | 0.21x | 0.21x | 0.13x | 0.12x | 0.12x | 0.12x | 0.12x | 0.11x | 0.13x | 0.14x | 0.14x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | 3.20x | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | -2.03x | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 1.81B | 1.92B | 1.92B | 1.71B | 1.83B | 1.93B | 1.94B | 1.98B | 2.08B | 1.88B | 1.73B | 1.82B |
| Equity Growth % | -0.8% | -0.53% | -1.22% | -13.62% | -12.23% | 2.62% | 12.26% | 9.08% | 12.35% | 0.39% | -11.57% | -13.14% |
| Book Value per Share | 18.89 | 21.37 | 20.98 | 19.65 | 21.28 | 22.61 | 22.76 | 23.33 | 25.48 | 23.15 | 21.76 | 22.96 |
| Total Shareholders' Equity | 1.81B | 1.92B | 1.92B | 1.71B | 1.83B | 1.93B | 1.94B | 1.98B | 2.08B | 1.88B | 1.73B | 1.82B |
| Common Stock | 3.12M | 3.09M | 3.01M | 2.79M | 2.72M | 2.7M | 2.68M | 2.67M | 2.66M | 2.5M | 2.48M | 2.47M |
| Retained Earnings | -2.07B | -1.95B | -1.82B | -1.71B | -1.5B | -1.37B | -1.33B | -1.24B | -1.12B | -999.7M | -1.09B | -976.89M |
| Treasury Stock | -60K | -60K | -60K | -62K | -62K | -62K | -62K | -62K | -62K | -62K | -63K | -63K |
| Accumulated OCI | -1.94M | 4.82M | 4.99M | 4.04M | 4.13M | 1.84M | 10.56M | -2.88M | -1.55M | 1.91M | -6.8M | -8.91M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |